Richard B. Emmitt

Mr. Emmitt is a Managing Director of The Vertical Group, a New Jersey-based medical device venture capital partnership that succeeded the venture capital activities of F. Eberstadt & Co. Mr. Emmitt has been recognized as one of the leading experts on the healthcare industry, with more than thirty years’ experience in healthcare-related venture capital, investment research, and investment banking.

He currently serves on the board of several public and private medical device companies including BioSet, ENTrigue Surgical, Galil Medical, Incumed, and Tornier. During the past five years,Mr. Emmitt previously served on the board of directors of American Medical Systems, ev3 , Micro Therapeutics and Wright Medical Group..

Mr. Emmitt was also involved in the successful development of SciMed Life Systems and Xomed Surgical Products, which were ultimately acquired by Boston Scientific and Medtronic, respectively.

He holds an M.B.A from The Rutgers School of Business and a B.A. from Bucknell University.

Richard B. Emmitt is the Founder/Managing Director at The Vertical Group, based in United States, North America. With a background in Venture Capital, Richard B. Emmitt has a rich history of leadership and innovation. Richard B. Emmitt studied MBA unknown @ Rutgers Business School Newark and New Brunswick. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.